For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $11.54 in the prior trading day, Wave Life Sciences Ltd (NASDAQ: WVE) closed at $11.27, down -2.34%. In other words, the price has decreased by -$2.34 from its previous closing price. On the day, 1.28 million shares were traded. WVE stock price reached its highest trading level at $11.335 during the session, while it also had its lowest trading level at $10.57.
Ratios:
Our goal is to gain a better understanding of WVE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.90 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.13.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $11.B. Riley Securities initiated its Buy rating on September 19, 2024, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 25 ’24 when BOLNO PAUL sold 50,000 shares for $15.00 per share. The transaction valued at 750,000 led to the insider holds 217,351 shares of the business.
PAUL BOLNO bought 50,000 shares of WVE for $750,000 on Nov 25 ’24. On Nov 15 ’24, another insider, BOLNO PAUL, who serves as the President and CEO of the company, sold 51,234 shares for $14.32 each. As a result, the insider received 733,671 and left with 217,351 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1760081024 and an Enterprise Value of 1442993792. For the stock, the TTM Price-to-Sale (P/S) ratio is 32.06 while its Price-to-Book (P/B) ratio in mrq is 11.81. Its current Enterprise Value per Revenue stands at 26.917 whereas that against EBITDA is -9.751.
Stock Price History:
The Beta on a monthly basis for WVE is -1.07, which has changed by 1.3696098 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is -19.66%, while the 200-Day Moving Average is calculated to be 32.85%.
Shares Statistics:
The stock has traded on average 1.48M shares per day over the past 3-months and 825670 shares per day over the last 10 days, according to various share statistics. A total of 148.39M shares are outstanding, with a floating share count of 117.59M. Insiders hold about 22.90% of the company’s shares, while institutions hold 73.95% stake in the company. Shares short for WVE as of 1734048000 were 7054249 with a Short Ratio of 5.57, compared to 1731628800 on 6449275. Therefore, it implies a Short% of Shares Outstanding of 7054249 and a Short% of Float of 7.960000000000001.
